Skip to content

Interest of MRI in Preoperative Staging for the Laryngeal and Hypopharyngeal Cancer

Interest of MRI in Preoperative Staging for the Laryngeal and Hypopharyngeal Cancer

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03132727
Acronym
Larynx MRI
Enrollment
73
Registered
2017-04-28
Start date
2017-03-23
Completion date
2019-11-22
Last updated
2020-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypopharyngeal Carcinoma, Laryngeal Carcinoma

Brief summary

To determine if MRI can detect preoperative invasion of cartilage by laryngeal and hypopharyngeal carcinoma, and to compare it to CT imaging and histopathology in excised larynges and/or hypopharynges.

Interventions

OTHERPharyngo laryngeal MRI

Patients will be outgoing a pharyngolaryngeal MRI, with injection of gadolinium, in addition to the CT imaging. They will have this MRI in case of doubt about cartilage invasion. It will be realised during the time between the CT imaging and the day of surgery. Device : gadolinium-based MRI contrast agent This will be realized according to the standard procedure.

Sponsors

Hospices Civils de Lyon
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient ≥18 years old * Patient with a laryngeal or hypopharyngeal cancer at any stage * Patient eligible for a surgical treatment in multidisciplinary consultation * Patient who did not oppose its participation to the study * Indication for performing an MRI in addition to CT at the discretion of the investigator

Exclusion criteria

* Patient with an ASA (American Society of Anesthesiologists, international anesthesia classification) score ≥ 3, * Patient with a chirurgical contraindication * Patient with a MRI contraindication * Pregnant or nursing woman * Adult requiring protection (guardianship, supervision) * Patient participating in interventional research (Excluding physiological studies and interventional research involving only minimal risks and constraints that do not interfere with the analysis of the primary outcome).

Design outcomes

Primary

MeasureTime frameDescription
Endoscopy1-4 weeksTumor stage and cartilage invasion as determined by endoscopy : invaded/non invaded/undetermined
CT scan1-4 weeksTumor stage and cartilage invasion as determined by CT scan : invaded/non invaded/undetermined
MRI1-4 weeksTumor stage and cartilage invasion as determined by MRI : invaded/non invaded/undetermined
Anatomopathological analysis2-4 weeksTumor stage and cartilage invasion as determined by histopathology in excised pieces : invaded/non invaded/undetermined

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026